Irf4 b cell
WebJan 20, 2024 · The transcription factor interferon regulatory factor 4 (IRF4) is critical for development of the immune system, especially B and T cells. The IRF4 International Consortium identified seven patients from six … WebIRF4. Interferon regulatory factor 4 (IRF4) also known as MUM1 is a protein that in humans is encoded by the IRF4 gene, [5] [6] [7] located at 6p25-p23. IRF4 functions as a key regulatory transcription factor in the development of human immune cells. [8] [9] The expression of IRF4 is essential for the differentiation of T lymphocytes and B ...
Irf4 b cell
Did you know?
WebMay 31, 2024 · Irf4/8 double-knockout mice show arrested B cell development at the cycling pre–B cell stage, with absence of immature IgM + B cells and high levels of pre-BCR expression ( Lu et al., 2003 ). Molecularly, both Irf4 and 8 induce germline transcription and promote L chain rearrangement and transcription ( Ma et al., 2008 ). WebApr 8, 2024 · IRF4 works in a dose-dependent manner in B cells, at low levels triggering the expression of the enzyme activation-induced deaminase (AID), thus driving somatic hypermutation and class switch recombination, and at high levels allowing the expression of Blimp-1 ( 21, 27 ), therefore being crucial for PC differentiation.
WebNov 22, 2024 · IRF4 is also required in B cells for germinal center formation and plasma cell differentiation ( 14 – 16 ). Because of IRF4’s unique role in mature B cells, we hypothesized that it may also have some functions earlier in B cell development that cannot be compensated for by IRF8. WebOct 6, 2024 · Sustained IRF4 expression is sufficient to directly repress BCL-6 expression and promote plasma cell differentiation, which may reflect the dose-dependent function …
WebApr 13, 2024 · The family/class of the large B-cell lymphomas (LBCL) in the 5th edition of the World Health Organization (WHO) classification of haematolymphoid tumors (WHO-HAEM5) features only a few major changes as compared to the 4th edition. In most entities, there are only subtle changes, many of them only representing some minor modifications in … WebMar 20, 2024 · It has been shown that IRF8 and SPI1 may contribute to BCL6 induction in antigen-engaged pre-GC-B cells, while IRF4 and PRDM1 repress BCL6 in light zone GC-B cells (16, 48). Moreover, the binding of BCL6 to its own 5′ regulatory region forms an autoregulatory circuit that limits its own expression in GC-B cells (Figure 2C) .
WebIrf4 -/-/Irf8 -/-B cells are hyperprolif-erative and fail to induce expression of the Ikaros family factors (Ikaros and Ai- olos) ( Ma et al., 2008). The IRF4 expression is induced by...
Web树突状细胞. 先天免疫和适应性免疫之间的桥梁. 2011年的诺贝尔生医奖得主史坦曼,发现树突状细胞(DC)是人类免疫细胞系统的司令官,号令主导免疫系统的各种功能。. DC的功能是吞噬、加工及呈递抗原,将交手过的癌细胞特征告诉辅助T细胞和B细胞。. 接受树 ... how is language used in 1984WebJP7239597B2 JP2024545734A JP2024545734A JP7239597B2 JP 7239597 B2 JP7239597 B2 JP 7239597B2 JP 2024545734 A JP2024545734 A JP 2024545734A JP 2024545734 A JP2024545734 ... highlandradio.comWebApr 11, 2024 · While there are also reports that B cell receptor and TCR signaling induces transient PS exposure on the cell surface ... Ifng, Irf4, Tnf, and Nr4a1 in EV + CD8 + T cells. Especially the effector cytokines IFN-γ and TNF-α are NFATc1 dependent . CD8 + T E cells are central to fight viral infection by cytotoxic lysis of infected cells . highland rainproof cargo bagWebNational Center for Biotechnology Information highland rainproof cargo bag 1041700WebThe IRF4/DUSP22 locus is rearranged in a newly recognized subtype of non-Hodgkin lymphoma, large B-cell lymphoma with IRF4 rearrangement. These lymphomas are uncommon, but are clinically distinct from morphologically similar lymphomas, including diffuse large B-cell lymphoma, high-grade follicular lymphoma, and pediatric-type … highland ramparts 750 lbWebJul 8, 2024 · Large B-cell lymphoma with IRF4 rearrangement (LBCL-IRF4) constitutes a novel provisional entity included in the classification of lymphoid tissue recently proposed … how is la nina identifiedWebJul 7, 2011 · Because deregulation of IRF4 expression by a t(6;14)(p25;q32) has already been described as a recurrent event in multiple myeloma 23 and because of the well-known function of IRF4 as transcription factor in B cells associated with oncogenic addiction, 24 we considered IRF4 to be the probable target of the translocation. highland railway river class